Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression
- 1 January 1996
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (8) , 980-986
- https://doi.org/10.1007/bf01084375
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Expression of multidrug resistance (MDR) genes in normal breast tissue, primary and advanced breast cancer and treatment outcomeAnti-Cancer Drugs, 1994
- Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonographyNuclear Medicine Communications, 1994
- The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast massesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristineEuropean Journal of Cancer and Clinical Oncology, 1991
- Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.Circulation, 1990
- The Clinical Relevance of Multidrug ResistanceCancer Investigation, 1990
- Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the LungsClinical Nuclear Medicine, 1989
- Breast carcinomas detected by thallium-201 scintigraphyCancer Letters, 1988